Pharmaceutical Trade and Supply Chain Survey, Q3 2020 – Coronavirus Disease 2019 (COVID-19) Impact

2020-09-15
Price :
Published : Sep-2020
No. of Pages : 49

Pharmaceutical Trade and Supply Chain Survey, Q3 2020 – Coronavirus Disease 2019 (COVID-19) Impact

Summary

This report provides an update on the assessment of how the pharmaceutical industry perceives the supply chain disruption caused by the COVID-19 pandemic, including the challenges associated with clinical trials, logistics, API and finished dose manufacturing.

Since the first case was diagnosed in Wuhan, China, in December 2019, COVID-19 cases have continued to rise rapidly across the globe.

Scope

– Report provides in-house analyst expertise on the results of a 5 minute survey of 75 GlobalData Pharma clients and prospects, which was fielded from July 7, 2020 to July 30, 2020.

Reasons to Buy

Objectives included –
– Benchmark companies’ primary concerns
– Determine the impact of COVID-19 to date on supply chains
– Assess companies’ strategic future plans
– Track changes to corporate strategy and attitudes

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) – Global Forecast to 2025

“The digital pathology market is projected to grow at a CAGR of 13.8% during the forecast period (2020–2025).” The global digital pathology market is projected to reach USD 1,054 million by 2025 from USD 553 million in 2020, at a CAGR of 13.8% during the forecast period. The key factors driving the growth of this market include the increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development & companion diagnostics, and increasing initiatives by industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent. “Adoption of artificial intelligence is expected to increase during the forecast period.” The adop......
$4950

Netherlands Healthcare, Regulatory and Reimbursement Landscape – CountryFocus

Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus Summary GlobalData, the industry analysis specialist, has released its latest report: "Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-hous......
$1995

Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletizing, Labeling & Serialization), Type (Tablet, Powder, Cream, Syrup, Aerosol), Region – Global Forecast to 2025

The pharmaceutical packaging equipment market is expected to grow at a CAGR of 7.4% in the forecast period. The global pharmaceutical packaging equipment market size is projected to reach USD 10.4 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 7.4% from 2020 to 2025. The growth of the market is driven by the rapidly growing generic & biopharmaceutical markets, growth in OTC drug sales, rising need for flexible & integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, and the introduction of regulatory standards on packaging & stringent norms against counterfeiting. However, factors such as the adoption of refurbished packaging equipment and the high cost of packaging equipment are expected to restrain market growth to a cer......
$4950

Central Retinal Vein Occlusion Disease – Global Clinical Trials Review, H2, 2020

Central Retinal Vein Occlusion Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "Central Retinal Vein Occlusion Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Central Retinal Vein Occlusion Clinical trials scenario. This report provides top line data relating to the clinical trials on Central Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated us......
$2500

Malignant Pleural Effusion Disease – Global Clinical Trials Review, H2, 2020

Malignant Pleural Effusion Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "Malignant Pleural Effusion Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Malignant Pleural Effusion Clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Pleural Effusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's......
$2500

Primary Immune Deficiency (PID) Disease – Global Clinical Trials Review, H2, 2020

Primary Immune Deficiency (PID) Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "Primary Immune Deficiency (PID) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Primary Immune Deficiency (PID) Clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Immune Deficiency (PID). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generate......
$2500

Rabies Disease – Global Clinical Trials Review, H2, 2020

Rabies Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "Rabies Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Rabies Clinical trials scenario. This report provides top line data relating to the clinical trials on Rabies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are c......
$2500

House Dust Mite Allergy Disease – Global Clinical Trials Review, H2, 2020

House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of House Dust Mite Allergy Clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary......
$2500

Measles Disease – Global Clinical Trials Review, H2, 2020

Measles Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "Measles Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Measles Clinical trials scenario. This report provides top line data relating to the clinical trials on Measles. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials a......
$2500

Menorrhagia Disease – Global Clinical Trials Review, H2, 2020

Menorrhagia Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "Menorrhagia Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Menorrhagia Clinical trials scenario. This report provides top line data relating to the clinical trials on Menorrhagia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. C......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy